Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Debt to Equity (2020)

Foghorn Therapeutics (FHTX) has 1 years of Debt to Equity data on record, last reported at $0.13 in Q4 2020.

  • For Q4 2020, Debt to Equity changed N/A year-over-year to $0.13; the TTM value through Dec 2020 reached $0.13, changed N/A, while the annual FY2020 figure was $0.13, N/A changed from the prior year.
  • Debt to Equity reached $0.13 in Q4 2020 per FHTX's latest filing, up from -$0.11 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.13 in Q4 2020 and bottomed at -$0.11 in Q3 2020.